Pfizer Is Allowing Poorer Nations to Manufacture Its Antiviral Coronavirus Pill
Pfizer announced on Tuesday that it is allowing its antiviral COVID-19 pill to be made in poorer nations throughout the world in an effort to help arm them with tools to combat the pandemic.
Pfizer said that under an agreement with the Medicines Patent Pool (MPP), the company will manufacture and supply its effective antiviral pill in 95 countries, including all low-income and lower-middle-income nations. The agreement covers roughly 53 percent of the world’s population.
Some upper-middle-income countries in Sub-Saharan Africa and nations that have shifted from lower-middle-income to upper-middle-income status in the past five years are also part of the agreement.